clinicalStudies
She
youngPatients
index
screeningBehavior
[(ImprovedDetection
FilipinoWomen
scanTime
novelTargetedTherapeuticOptions
novelTechnique
results
BACKGROUND
18F-FDGPET/CTImages
hormonalContraceptionUse
intake
strongIndependentPrognosticFactor
novelTherapeuticOptions
selectedCases
betterOutcome
tumorDetectability
components
imagesneed
[(X-rayMammography
we
[(association
[(risk
cohortStudy
agreement
longScanTime
third-degree
smallMoleculeInhibitors
appropriateness
theResulting
powerfulTechnique
breastExamination
CXCR4-directedPETImaging
contrastAgents
Metastases
complexDisease
[(BreastCancer
definitiveDiagnosis
Anthracyclines
Aims
amount
theirEmergingRole
performance
analysis
Osteopontin-750Accumulation
CXCR4-targetedPETImaging
allotting
unenhancedMRITechniques
osteopontin-basedProbe
p
SeromaFormation
article
therapeuticOptions
BetterUnderstanding
cTnLevels
relationship
moreSpecificApplications
homologousRecombinationPathway
address
[(TraumaticNeuroma
HealthcarePolicyMakers
dose-dependentReduction
CoxProportionalHazardRegressionModels
cancerRiskPerception
signature
initialResults
rareClinicalEntity
doses
search
screeningMammography
fourPatients
excision
largerProspectiveStudies
[(breast
OurFindings
probe
Information
imagingProtocol
symptomControl
theirAbility
tumor-to-backgroundRatios
radicalSurgicalApproaches
contrast-enhancedScreeningTools
differentialDiagnosis
recentDanishCohortStudy
imagingTechnique
MedianAmount
24ApplicableCases
breastImagingModality
TenStudies
ManyFeatures
They
lowCTnLevels
cardiotoxicityDiagnosis
evaluation
targetedTherapeuticOptions
images
importantCornerstone
summaryHazardRatios
comprehensiveSearch
highIndex
significantAdvances
surgicalExcision
targetedOptions
she
novelTargetedOptions
Ulceration
alternativeScreeningTools
they
[(BreastCancer
We
increase
Forty-threeCases
BRD4Regulation
disease
IORT
biomarker
SimilarTowaveletFilter
membraneTypeMR
understanding
581Patients
discovery
options
recombinationPathway
Mammography
Radiotherapy
locoregionalRadiotherapy
role
elderlyPatient
treatment
[(recentCohortStudy
postmenopausalPatient
multiresolutionResult
contraceptionUse
RESULTS
radiotherapy
membraneTypeMannoseReceptor
identification
primaryTumour
novelPowerfulTechnique
40
[(involved
collectedSignatures
novelOptions
cornerstone
ObservationalStudies
troponins
Extra-TerminalBETProteins
bleeding
mutations
MRI
technique
differentStudies
FemalePatients
strongAssociation
five
largerStudies
[(Anti-HER2Therapies
highCosts
[(experiences
lesion
case
costs
12SampledWomen
FurtherDevelopment
studies
neuroma
[(BACKGROUND
95%ConfidenceIntervals
I2
it
ConservativeTreatment
[(radicalSurgicalApproaches
HerPresentation
observedVariation
directRelationship
prospectiveStudies
screeningTools
Comparison
anti-HER2Therapy
Efforts
CardiacTroponins
MedianFollow-up
herDisease
Diagnosis
association
result
%
466%
[(they
alternativeContrast-enhancedScreeningTools
towaveletFilter
%ConfidenceIntervals
theirInhibition
[(CXCR4
MedianAge
X-rayMammography
study
[(ObservationalStudies
time
mammographicImages
diagnosticPerformance
numerousGene-expression-basedSignatures
[(complexDisease
research
MRITechniques
aim
the
mostPatients
infraredFluorescentImaging
familialCancerClustering
onePatient
most
reproducibilityStudies
prognosticSignatures
24Cases
subcutaneousBreastTumor
Anti-HER2Therapies
breastCancerEffects
decreases
glycosylationSites
necessity
ImprovedDetection
currentDevelopments
DiagnosticEvaluation
strongContrast
FluorescenceImagingExVivo
markedReduction
OurLiteratureReview
increasedRisk
respondents
BETProteins
standardizedImagingProtocol
risk
heterogeneousCancer
DanishCohortStudy
barcodeMode
clinicians
TraumaticNeuroma
TraumaticBreastNeuromas
follow-up
signatures
gene-expression-basedPrognosticSignatures
numerousGene-expression-basedPrognosticSignatures
MSOTImaging
deterioration
longTime
numerousPrognosticSignatures
subtype-specificSignature
breastNeuromas
higher
ThirteenPatients
features
theirCardiotoxicities
MRIProtocols
traumaticNeuroma
imagingFeatures
development
diagnosis
update
numerousSignatures
availableContrastAgents
gene-expression-basedSignatures
improvedBreastCancerOS
cases
1
detection
CoxHazardRegressionModels
repair
signalIntensity
use
SelectiveBinding
subjectiveRisk
binding
Bromodomain
12-15%
involved
retrospectiveAnalysis
ConventionalX-rayMammography
BRD4PharmacologicalInhibition
higherSUVmax
PETImaging
Breast
exhibiting
adjustment
1062Patients
FurtherResearch
[(40
breast
detectionofBreastCancer
recentCohortStudy
commonCancer
BRCAnessPhenotype
routineClinicalBiomarker
Transcripts
higherResolution
age
moleculeInhibitors
PatientDemographics
prolongedRecovery
experiences
segmentationAlgorithm
metastaticDisease
BRD4Inhibition
response
pharmacologicalInduction
cTn
SixGlycosylationSites
clinicalBreastExamination